Amgen Inc. (AMGN) is a leading biotechnology company headquartered in Thousand Oaks, California. It specializes in the discovery, development, manufacturing, and delivery of innovative human ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
Focusing on the establishment of Sino Biological‘s Center for Bioprocessing (C4B) in Houston, it highlights how the ...
Sidewinder achieves highly accurate assembly of long DNA sequences from scratch, offering a new leap forward for programmable biology ...
The Central Board of Secondary Education schedules Class 10 and 12 exams from February 17, 2026, highlighting key questions and topics.
DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...
From months to minutes: King County Sheriff’s Office among the first in WA to use new DNA technology
Crime scene DNA test results in minutes rather than weeks or months. It’s a new technology now in the hands of investigators at the King County Sheriff’s Office. It’s called the Rapid DNA machine. “It ...
Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying ...
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...
New York startup Helaina, which ferments microbes to create recombinant breast milk proteins, is ushering in a new dawn for ...
When a student peers into a microscope for the first time, they are not just observing cells--they are stepping into a world where science can heal, protect, and transform lives. At the School of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results